Intensive luteal phase support after GnRH agonist trigger: It does help

Reproductive BioMedicine Online

Volumn 25, Issue 3, 2012, Pages 329-330

  Benadiva, Claudio ^a   Engmann, Lawrence ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; LUTEINIZING HORMONE; PROGESTERONE;

COHORT ANALYSIS; EMBRYO TRANSFER; HUMAN; LETTER; LOW DRUG DOSE; LUTEAL PHASE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE;

BUSERELIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEAL PHASE; OVULATION INDUCTION; PREGNANCY;

EID: 84865736553     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.06.010     Document Type: Letter

References (10)

1. J. Andreyko, M. Murray, and C. Soto-Albors Use of combined oral and vaginal estradiol and IM and vaginal progesterone in luteal phase of antagonist cycles triggered with GnRH agonist results in good clinical pregnancy rates Fertil. Steril. 45 2011 S25
2. L. Engmann, and C. Benadiva Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support Fertil. Steril. 97 2012 531 533
3. L. Engmann, A. Diluigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil. Steril. 89 2008 84 91
4. D. Griffin, C. Benadiva, N. Kummer, T. Budinetz, J. Nulsen, and L. Engmann Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders Fertil. Steril. 97 2012 1316 1320
5. P. Humaidan Response: intensive luteal phase support with oestradiol and progesterone after GnRH agonist triggering: does it help? Reprod. Biomed. Online 24 2012 682 683
6. P. Humaidan, S. Kol, L. Engmann, C. Benadiva, E.G. Papanikolaou, and C.Y. Andersen Should Cochrane reviews be performed during the development of new concepts? Hum. Reprod. 27 2012 6 8
7. T. Imbar, S. Kol, F. Lossos, Y. Bdolah, A. Hurwitz, and R. Haimov-Kochman Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support Hum. Reprod. 27 2012 753 759
8. N. Kummer, C. Benadiva, R. Feinn, J. Mann, J. Nulsen, and L. Engmann Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist Fertil. Steril. 96 2011 63 68
9. R. Orvieto Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help? Reprod. Biomed. Online 24 2012 680 681
10. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin Fertil. Steril. 95 2011 2715 2717